Author

Srinivasa Rao Ganipisetty

Institution: Vignan's Foundation for Science, Technology & Research

Observed institutions: Vignan's Foundation for Science, Technology & Research, Aurigene Discovery Technologies (India)

ORCID: 0009-0000-9745-3599

Observed ORCID: 0009-0000-9745-3599

OpenAlex ID: A5119299655

Development and Optimization of a Sensitive LC–MS/MS Method for the Quantification of N‐Nitroso Bisoprolol in Pharmaceutical Formulations

2026 · Rajesh Damarapurapu, Vinod Kumar Manglige, et al. · Separation Science Plus · 12

Abstract 1392: Preclinical In vivo evaluation of efficacy, pharmacokinetics and pharmacodynamics of novel PRMT5 inhibitors in multiple tumor models

2018 · Dinesh Chikkanna, Sunil Kumar Panigrahi, et al. · Cancer Research · 1

Identification, synthesis, and structural characterization of potential impurities of cabozantinib: tyrosine kinase inhibitor

2026 · Srinivasa Rao Ganipisetty, Satyasree Nannapaneni, et al. · Chemical Papers

Microwave‐Assisted Synthesis and Structural Characterization of N‐Nitroso Tofacitinib: Janus Kinase Inhibitor

2025 · Srinivasa Rao Ganipisetty, Satyasree Nannapaneni, et al. · ChemistrySelect

Identification, Synthesis, and Characterization of Novel Impurities of Azilsartan Medoxomil, AT1 Receptor Antagonist

2025 · Srinivasa Rao Ganipisetty, Srikanth Yerra, et al. · ChemistrySelect

Abstract A174: Novel inhibitors of protein arginine methyltransferase 5 (PRMT5) for the treatment of solid tumors

2018 · Dinesh Chikkanna, Sunil Kumar Panigrahi, et al. · Molecular Cancer Therapeutics

Works count: 6

Citation count: 13

H-index: 1

I10-index: 1